Vistagen Therapeutics, Inc.

VTGN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001411685

SEC filings (opens in a new tab)

Insider trades, last 90 days

None

No open-market purchases or sales were filed in the last 90 days.

View insider trades

13F holders, Q2 2026

48

−8 vs. Q1 2026
Total value $2.54M

View 13F holders

Superinvestors holding VTGN

0

None of the superinvestors held VTGN at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by VTGN insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Aug 9, 2023	Aug 7, 2023	COMMODORE CAPITAL LP10% Owner	PPurchaseCommon Stock	+775.76K	$23.15	+$17.96M	1.58M	+97.1%	SEC
Aug 22, 20225:12 PM ET	Aug 18, 2022	GIN JERRY BDirector	PPurchaseCommon Stock	+100K	$0.1787	+$17.87K	100K	New position	SEC
Aug 22, 20225:12 PM ET	Aug 18, 2022	GIN JERRY BDirector	PPurchaseCommon Stock	+100K	$0.1787	+$17.87K	100K	New position	SEC
Aug 19, 20223:45 PM ET	Aug 17, 2022	Adler Reid G.CHIEF LEGAL OFFICER	PPurchaseCommon Stock	+300K	$0.1697	+$50.91K	334.63K	+866.3%	SEC
Aug 18, 20223:56 PM ET	Aug 17, 2022	Singh ShawnCHIEF EXECUTIVE OFFICER	PPurchaseCommon Stock	+600K	$0.172	+$103.2K	626.23K	+2,287.1%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in VTGN at the end of Q2 2026.

Institutions holding VTGN in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
COMMODORE CAPITAL LP	2,788,620	$630.23K	0.04%	+2,788,620	New
VANGUARD CAPITAL MANAGEMENT LLC	1,574,200	$355.77K	0.00%	00.0%	Unchanged
TWO SIGMA INVESTMENTS, LP	847,992	$191.65K	0.00%	+378,373+80.6%	Added
ACADIAN ASSET MANAGEMENT LLC	794,579	$178K	0.00%	+204,916+34.8%	Added
RENAISSANCE TECHNOLOGIES LLC	730,500	$165.09K	0.00%	+439,200+150.8%	Added